OBJECTIVE -To evaluate the 24-h blood pressure profile in normoalbuminuric type 2 diabetic patients.
M
icroalbuminuria is a known risk factor for the development of clinical nephropathy in type 1 and type 2 diabetes (1-4), and it is also an independent risk factor for cardiovascular disease (4) . The cutoff value used to define microalbuminuria (urinary albumin excretion rate [UAER] Ͼ20 g/min or Ͼ30 mg/24 h) (5) was defined by consensus, based on studies performed in patients with type 1 and type 2 diabetes in the 1980s (1) (2) (3) (4) . However, there is emerging evidence that patients with diabetes in the high-normal range of UAER are already at high risk for progressing to microalbuminuria or even more advanced stages of renal disease (6 -9) .
Arterial hypertension follows the establishment of microalbuminuria in patients with type 1 diabetes (10) . In type 2 diabetes, this relationship is not that clear because hypertension is a common feature in these patients, regardless of renal status (11) . Ambulatory 24-h blood pressure monitoring has a better correlation with target organ damage than doctor's office blood pressure measurements (12) and allows the evaluation of blood pressure parameters, such as circadian blood pressure rhythm and blood pressure loads. Nondiabetic healthy subjects in the high-normal range of UAER (15) (16) (17) (18) (19) (20) mg/24 h) have higher blood pressure levels than nondiabetic individuals in the lower ranges of UAER (13) . The same seems to be true for patients with type 1 diabetes and UAER above the median (4.2 g/min) (14) , suggesting that highnormal albuminuria is associated with an increase in blood pressure values. Nevertheless, no information is available concerning the relationship between UAER and 24-h ambulatory blood pressure in type 2 diabetes. Therefore, we hypothesized that patients with type 2 diabetes in the high-normal range of UAER would have higher blood pressure levels than patients in the lower ranges. The aim of this study was to evaluate the blood pressure patterns and the clinical and laboratory profile of normoalbuminuric patients with type 2 diabetes according to their UAER levels.
RESEARCH DESIGN AND METHODS
-A cross-sectional study was performed in normoalbuminuric type 2 diabetic patients regularly attending the diabetes outpatient clinic at Hospital de Clínicas de Porto Alegre. Type 2 diabetes was defined based on World
Health Organization criteria (i.e., Ͼ30 years of age at onset of diabetes, no previous episode of ketoacidosis or documented ketonuria, and treatment with insulin only after 5 years of diagnosis) (15) . Patients with other renal diseases, cardiac arrhythmia, or postural hypotension were excluded. Normoalbuminuric patients were selected based on UAER values Ͻ20 g/min on at least two occasions over the preceding 6 months while on their usual antihypertensive drugs. Patients using ACE inhibitors had these medications suspended for 1 week, after which a 3rd UAER measurement was performed. Of the 92 patients recruited, 2 had UAER Ͼ20 g/min and were not included in the study. Therefore, UAER was consistently within the normoalbuminuric range for all of the patients included. The study protocol was approved by the hospital's research ethics committee, and informed consent was obtained from all patients.
Clinical, blood pressure, and echocardiographic evaluation Demographic and anthropometric data were collected by means of an interview and clinical examination, as previously described (16) . Indirect ophthalmoscopy was performed through dilated pupils by an ophthalmologist. For the purpose of this study, patients were classified only according to the presence or absence of any degree of diabetic retinopathy.
blood pressure evaluations were performed 1 week after withdrawal from all antihypertensive medications. Office blood pressure was measured with a mercury sphygmomanometer, using the left arm and with the patient in a sitting position, after a 5-min rest. The mean of two measurements was considered. The patient was classified as hypertensive based on use of antihypertensive drugs and/or office blood pressure Ն140/90 mmHg. Ambulatory 24-h blood pressure monitoring was performed by oscillometry (Spacelabs 90207), with a 15-min interval during the daytime and a 20-min interval during the nighttime. Patients were advised to maintain their usual daily activities. Sleep time was recorded as the period between the time when the patient went to bed and the time when the patient woke up the next morning. The means of 24-h, daytime, and nighttime systolic and diastolic blood pressure were recorded. blood pressure load was defined as the percentage of 24-h and daytime blood pressure Ն140/90 mmHg and of nighttime blood pressure Ն120/80 mmHg. Pulse pressure was the difference between the systolic and diastolic blood pressure means. Patients with a night/day blood pressure ratio Ͼ0.9 were considered to be nondippers.
Echocardiograms (n ϭ 60) were obtained according to the recommendations of the American Society of Echocardiography (17), using standard parasternal and apical views with subjects in the partial left decubitus position and using a commercially available instrument (Sonus 1000; Hewellet Packard). Left ventricular mass was calculated based on wall thickness (end-diastolic ventricular internal diameter, end-diastolic interventricular septum, and posterior wall) and was adjusted to body surface area. The cardiologist who performed the echocardiograms was unaware of the subjects' clinical and laboratory characteristics.
Laboratory methods UAER was measured in sterile 24-h timed urine samples by immunoturbidimetry (Microlab; Ames, Tarrytown, NY). HbA 1c (AlC) was measured by a high-performance liquid chromatography system (normal range 2.7-4.3%, Merck-Hitachi 9100). Fasting plasma glucose was measured by the glucose-peroxidase colorimetric enzymatic method (Biodiagnostica). Creatinine was measured by the Jaffé method and the lipid profile by a colorimetric method. The glomerular filtration rate was determined in 67 patients by the single-injection 51 Cr-EDTA technique (18) .
Statistical analysis
One-way ANOVA or the 2 test were used to compare clinical and laboratory data. The Bonferroni test was used to determine differences between groups. Quantitative variables without normal distribution were submitted to logarithmic transformation. Data are expressed as the means Ϯ SD, except for triglycerides, serum creatinine, and blood pressure loads, which are expressed as the median (range). Correlations were performed with the Pearson's 2 (log-UAER versus blood pressure means and left ventricular posterior wall thickness) or Spearman's rank correlation (log-UAER versus blood pressure loads) tests, depending on the distribution of variables. Multiple linear regression was performed with log-UAER as the dependent variable. P values Ͻ0.05 (two tailed) in the univariate analysis were considered to be significant.
RESULTS -There was a positive and significant correlation found between log-UAER and systolic office (r ϭ 0.243, P ϭ 0.021), systolic 24-h (r ϭ 0.280, P ϭ 0.008) (Fig. 1) , systolic daytime (r ϭ 0.264, P ϭ 0.013) and systolic nighttime (r ϭ 0.261, P ϭ 0.013) blood pressure, as well as for log-UAER and systolic blood pressure loads (24-h: r ϭ 0.353, P ϭ 
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DIABETES CARE, VOLUME 28, NUMBER A positive and significant correlation between the log-UAER and left ventricular posterior wall thickness (r ϭ 0.359, P ϭ 0.010) was also observed. This supports the hypothesis that UAER is associated with target-organ injury, even if it is within the normal range, probably because of higher blood pressure levels. There was no association between log-UAER and the other echocardiographic parameters analyzed, such as left ventricular mass, septum thickness, and left atrium size.
Patients were divided into four groups according to UAER (1st group: Ͻ5 g/min; 2nd group: Ն5-10 g/min; 3rd group: Ն10 -15 g/min; and 4th group: Ն15-20 g/min) ( Table 1) . Patients in the 4th UAER group had longer diabetes duration than patients in the 1st group. In terms of laboratory characteristics, patients in the 1st group of UAER had the lowest levels of total cholesterol. The prevalence of diabetic retinopathy increased progressively from the 1st to the 4th UAER group (27.3, 43.8, 45.5, and 66.7%; P ϭ 0.029 for trend). Mean age, BMI, proportion of male sex, smokers, and hypertensive patients were similar in the four groups, as was the ethnic group distribution.
Office blood pressure was similar in all groups (Table 1) . In general, patients belonging to the 1st UAER group (UAER Ͻ5 g/min) had lower ambulatory systolic blood pressure levels than patients with higher UAER levels. Systolic blood pressure values for the 1st, 2nd, 3rd, and 4th UAER groups, respectively, were as follows: 123.0 Ϯ 10. Nighttime diastolic blood pressure levels were lower in the 1st group (UAER Ͻ5 g/min) compared with the 3rd group (Ն10 -15 g/min): 67.5 Ϯ 9.4 vs. 75.9 Ϯ 14.4 mmHg (P ϭ 0.05). However, no difference was observed for the 2nd and 4th groups: 72.7 Ϯ 7.9 and 67.2 Ϯ 10.4 mmHg for 24-h values (P Ͼ 0.05). There were no differences among the groups, respectively, regarding the other diastolic blood pressure parameters: 74.5 Ϯ 8.5, 77.9 Ϯ 7.8, 80.2 Ϯ 13.4, and 73.1 Ϯ 7.6 mmHg for 24-h values (ANOVA P ϭ 0.122); 77.9 Ϯ 9.2, 80.3 Ϯ 8.4, 82.6 Ϯ 13.1, and 75.5 Ϯ 8.9 mmHg for daytime blood pressure (ANOVA P ϭ 0.263); 7.4% (range 0 -73.2), 16.6% (0 -89.1), 17.1% (0 -94.4), and 7.4% (0 -58.4) for 24-h blood pressure loads (ANOVA P ϭ 0.076); 6.8% (0 -75.5), 14.0% (0 -56.1), 10.0% (0 -96.4), and 3.6% (0 -57.4) for daytime blood pressure loads (ANOVA P ϭ 0.399); and 8.3% (0 -86.7), 14.5% (0 -96.7), 17.9% (0 -100.0), and 4.7% (0 -60) for nighttime blood pressure loads (ANOVA P ϭ 0.356). Analyzing the nocturnal blood pressure descent, there was no difference among the groups, respectively, in the prevalence of nondippers for systolic blood pressure (64.9, 71.9, 54.5, and 40.0%; P ϭ 0.289) and diastolic blood pressure (35.1, 43.8, 54.5, and 30.0%; P ϭ 0.585). Multivariate regression analyses were performed with log-UAER as the dependent variable. Diabetes duration, cholesterol, fasting plasma glucose and serum creatinine were included in the model as independent variables. In each regression model, only one blood pressure parameter was included as an independent variable. UAER remained correlated with 24-h systolic blood pressure (R ϭ 0.45, R a 2 ϭ 0.16; P ϭ 0.004), daytime systolic blood pressure (R ϭ 0.45, R a 2 ϭ 0.15; P ϭ 0.003), nighttime systolic blood pressure (R ϭ 0.44, R a 2 ϭ 0.15; P ϭ 0.017), 24-h systolic blood pressure loads (R ϭ 0.47, R a 2 ϭ 0.17; P ϭ 0.001), daytime systolic blood pressure loads (R ϭ 0.47, R a 2 ϭ 0.17; P ϭ 0.001), nighttime systolic blood pressure loads (R ϭ 0.42, R a 2 ϭ 0.13; P ϭ 0.014), 24-h pulse pressure (R ϭ 0.44, R a 2 ϭ 0.15; P ϭ 0.031), and daytime pulse pressure (R ϭ 0.45, R a 2 ϭ 0.15; P ϭ 0.017). This was not true for mean nighttime pulse pressure (R ϭ 0.40, R a 2 ϭ 0.11; P ϭ 0.079). Similar results were obtained with alternative models in which cholesterol levels were replaced by triglycerides (data not shown).
CONCLUSIONS -In this sample of normoalbuminuric type 2 diabetic patients, a positive correlation was observed between UAER and systolic blood pressure indexes. Furthermore, these patients had more retinopathy and increased left ventricular posterior wall thickness. Stratification of the patients according UAER level disclosed that patients with UAER Ն5 g/min already had a worse cardiovascular risk profile. However, because of the limited number of patients in the 4th group (UAER Ն15-20 g/min, n ϭ 10), some of blood pressure differences between this and the 1st group did not reach conventional statistical significance.
In a previous study using office blood pressure measurements and only one morning UAER sample, higher blood pressure levels, as well as an increased prevalence of diabetic retinopathy, were observed in type 2 diabetic patients with high-normal albuminuria (12.5-30 mg/l) (19) . A similar association between UAER and blood pressure levels was reported in healthy subjects (13) . Previous studies in nondiabetic hypertensive (20) and normoalbuminuric type 1 diabetic (14) patients showed high-normal levels of albuminuria were associated with increased ambulatory blood pressure levels. In nondiabetic hypertensive patients, high-normal UAER was found to be related to left ventricular hypertrophy (20) . Furthermore, high-normal levels of albu- minuria (Ն4.8 g/min) have been reported to be an independent risk factor for coronary artery disease and all causes of mortality in a 9-year cohort study of subjects from Copenhagen (21).
The association of UAER with diabetic retinopathy and left ventricular wall thickness was probably related to increased systolic blood pressure in these patients. The increased systolic blood pressure observed could be caused by decreased compliance in the major arteries. In fact, we observed higher pulse pressure levels in this sample of patients. Higher pulse pressure was also reported in type 2 diabetic patients with more advanced diabetic nephropathy (micro-and macroalbuminuria) and proliferative retinopathy (22).
The data concerning the current sample of type 2 diabetic patients, along with previous data on type 1 diabetic patients and nondiabetic healthy and hypertensive subjects, suggest that albuminuria seems to be a continuous risk marker for the development of target organ damage (such as retinopathy, left ventricular hypertrophy, and coronary artery disease) and death. However, clinicians need a precise reference value to adequately guide patients' treatment. UAER Ͼ10 g/ min has been associated with micro-and macroalbuminuria on Cox regression analysis in type 1 and type 2 diabetic patients (8, 9) . Our data indicate that patients with even lower levels of UAER are at risk.
It is important to point out that our results are based on a cross-sectional study and that our conclusions are limited to the observation of an association between cardiovascular risk factors and UAER. The establishment of a cause and effect relationship will require prospective cohort studies.
In conclusion, normoalbuminuric type 2 diabetic patients with UAER Ն5 g/min should be considered to have a high cardiovascular risk profile for which intense treatment is indicated, especially with regard to blood pressure control, so as to reduce both cardiovascular mortality and progression to more advanced stages of diabetic nephropathy. Prospective intervention studies are needed to confirm whether these patients will in fact benefit from such an aggressive approach. 
